CS
FMI

Candriam SCA’s Foundation Medicine, Inc. FMI Stock Holding History

Candriam SCA’s Portfolio FMI Stock Details FMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-30,000
Closed -$554K – 647
2015
Q3 		$554K Hold
30,000
– – 0.01% 518
2015
Q2 		$1.01M Buy
+30,000
New +$1.21M 0.02% 444

Other funds holding FMI

GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
MRM
Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Candriam SCA's FMI Position: Q4 2015 in Review

Candriam SCA sold out of Foundation Medicine, Inc. (FMI) in Q4 2015, closing a stake of 30,000 shares — an estimated $554K sold.

Candriam SCA first reported a position in FMI in Q2 2015 and held it in 2 quarters. The position peaked at $1.01M in Q2 2015. 99 funds tracked by Wall St. Rank hold FMI as of Q4 2015.

  • Candriam SCA reported no remaining Foundation Medicine, Inc. position as of Q4 2015 after selling out during the quarter.
  • Candriam SCA sold 30,000 Foundation Medicine, Inc. shares in Q4 2015, an estimated $554K.
  • Candriam SCA first reported a position in Foundation Medicine, Inc. in Q2 2015 and held it in 2 quarters.
  • Candriam SCA's Foundation Medicine, Inc. position peaked at $1.01M in Q2 2015.
  • 99 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q4 2015.

Based on Candriam SCA's 13F filing for Q4 2015, filed 25 Jan 2016.